| |
 |
ARTICLES 
|
|
| The dose dilemma |
| GP Canellos |
|
JCO Sep 1 1988: 1363–1364.
[PDF]
|
 |
| More is better |
| WM Hryniuk |
|
JCO Sep 1 1988: 1365–1367.
[PDF]
|
|
|
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer |
| |
WP Peters, EJ Shpall, RB Jones, GA Olsen, RC Bast, JP Gockerman, and JO Moore |
| |
JCO Sep 1 1988: 1368–1376.
[Abstract]
[PDF]
|
|
|
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer |
| |
IF Tannock, NF Boyd, G DeBoer, C Erlichman, S Fine, G Larocque, C Mayers, D Perrault, and H Sutherland |
| |
JCO Sep 1 1988: 1377–1387.
[Abstract]
[PDF]
|
|
|
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer [published erratum appears in J Clin Oncol 1989 Jan;7(1):145] |
| |
JN Ingle, LK Everson, HS Wieand, JK Martin, HJ Votava, LE Wold, JE Krook, SA Cullinan, JK Paulsen, and DI Twito |
| |
JCO Sep 1 1988: 1388–1396.
[Abstract]
[PDF]
|
|
|
A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer |
| |
L Silvey, JT Carpenter, Jr, RH Wheeler, J Lee, and C Conolley |
| |
JCO Sep 1 1988: 1397–1400.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study |
| |
A Rossi, R Molinari, P Boracchi, M Del Vecchio, E Marubini, M Nava, L Morandi, R Zucali, S Pilotti, and C Grandi |
| |
JCO Sep 1 1988: 1401–1410.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report |
| |
AM Carella, AM Congiu, E Gaozza, P Mazza, P Ricci, G Visani, G Meloni, G Cimino, L Mangoni, and P Coser |
| |
JCO Sep 1 1988: 1411–1416.
[Abstract]
[PDF]
|
|
|
Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases |
| |
P Fenaux, R Beuscart, JL Lai, JP Jouet, and F Bauters |
| |
JCO Sep 1 1988: 1417–1424.
[Abstract]
[PDF]
|
|
|
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia |
| |
HS Maurer, PG Steinherz, PS Gaynon, JZ Finklestein, HN Sather, GH Reaman, WA Bleyer, and GD Hammond |
| |
JCO Sep 1 1988: 1425–1432.
[Abstract]
[PDF]
|
|
|
Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy |
| |
MF Schray, A Martinez, AE Howes, KC Podratz, SC Ballon, GD Malkasian, Jr, and BI Sikic |
| |
JCO Sep 1 1988: 1433–1439.
[Abstract]
[PDF]
|
|
|
Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens |
| |
EA Wiebke, SA Rosenberg, and MT Lotze |
| |
JCO Sep 1 1988: 1440–1449.
[Abstract]
[PDF]
|
|
|
Bacillus Calmette-Guerin therapy alters the progression of superficial bladder cancer |
| |
HW Herr, VP Laudone, RA Badalament, HF Oettgen, PC Sogani, BD Freedman, MR Melamed, and WF Whitmore, Jr |
| |
JCO Sep 1 1988: 1450–1455.
[Abstract]
[PDF]
|
|
|
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome |
| |
A Manni, M Bartholomew, R Caplan, A Boucher, R Santen, A Lipton, H Harvey, M Simmonds, D White-Hershey, and R Gordon |
| |
JCO Sep 1 1988: 1456–1466.
[Abstract]
[PDF]
|
|
|
Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology |
| |
CY Fung, LA Kalish, GL Brodsky, JP Richie, and MB Garnick |
| |
JCO Sep 1 1988: 1467–1473.
[Abstract]
[PDF]
|
|
|
Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis |
| |
JB Sorensen, HH Hansen, M Hansen, and P Dombernowsky |
| |
JCO Sep 1 1988: 1474–1480.
[Abstract]
[PDF]
|
|
|
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience |
| |
GG Cornwell, 3d, TF Pajak, S Kochwa, OR McIntyre, LP Glowienka, K Brunner, S Rafla, M Coleman, MR Cooper, and E Henderson |
| |
JCO Sep 1 1988: 1481–1490.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity |
| |
AE Chang, T Kinsella, E Glatstein, AR Baker, WF Sindelar, MT Lotze, DN Danforth, Jr, PH Sugarbaker, EE Lack, and SM Steinberg |
| |
JCO Sep 1 1988: 1491–1500.
[Abstract]
[PDF]
|
|
|
Dose-response in the treatment of breast cancer: a critical review |
| |
IC Henderson, DF Hayes, and R Gelman |
| |
JCO Sep 1 1988: 1501–1515.
[Abstract]
[PDF]
|
|
|
Evaluation of clinical competence in medical oncology training programs |
| |
JH Glick, BA Chabner, and JA Benson, Jr |
| |
JCO Sep 1 1988: 1516–1519.
[Abstract]
[PDF]
|
|
| Fertility after chemotherapy for ovarian germ cell tumors |
| GJ Rustin, ES Newlands, RH Begent, and KD Bagshawe |
|
JCO Sep 1 1988: 1520a–1521.
[PDF]
|
|
| Is adjuvant therapy justified for women with small breast cancers? |
| DB Duggan |
|
JCO Sep 1 1988: 1520b.
[PDF]
|
|
| Maintenance or no maintenance treatment in AML? |
| C Sauter |
|
JCO Sep 1 1988: 1521–1522.
[PDF]
|
|
